Company Description

Alnair Therapeutics is developing the next generation of targeted oncology therapies by targeting cancer metabolism directly. Their proprietary tumor seeking Alnair Lactate-reacting Nanoparticle (ALN) platform makes trusted drugs Safer, Targeted, and Dose Intensifying!